PCM
MJN

Penserra Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Penserra Capital Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,610
Closed -$143K – 615
2017
Q1 		$143K Sell
1,610
-139
-8% -$11.4K 0.01% 267
2016
Q4 		$123K Buy
1,749
+376
+27% +$28K 0.01% 309
2016
Q3 		$108K Buy
1,373
+673
+96% +$57.4K 0.01% 264
2016
Q2 		$63K Buy
700
+233
+50% +$19.7K 0.01% 273
2016
Q1 		$39 Buy
467
+151
+48% +$11.2K ﹤0.01% 325
2015
Q4 		$25K Buy
+316
New +$24.9K ﹤0.01% 381

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Penserra Capital Management's MJN Position: Q2 2017 in Review

Penserra Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,610 shares — an estimated $143K sold.

Penserra Capital Management first reported a position in MJN in Q4 2015 and held it in 6 quarters. The position peaked at $143K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Penserra Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Penserra Capital Management sold 1,610 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $143K.
  • Penserra Capital Management first reported a position in Mead Johnson Nutrition Company in Q4 2015 and held it in 6 quarters.
  • Penserra Capital Management's Mead Johnson Nutrition Company position peaked at $143K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Penserra Capital Management's 13F filing for Q2 2017, filed 7 Aug 2017.